205 related articles for article (PubMed ID: 29752026)
1. Safety of a heat-stable rotavirus vaccine among children in Niger: Data from a phase 3, randomized, double-blind, placebo-controlled trial.
Coldiron ME; Guindo O; Makarimi R; Soumana I; Matar Seck A; Garba S; Macher E; Isanaka S; Grais RF
Vaccine; 2018 Jun; 36(25):3674-3680. PubMed ID: 29752026
[TBL] [Abstract][Full Text] [Related]
2. Rotavirus vaccine efficacy up to 2 years of age and against diverse circulating rotavirus strains in Niger: Extended follow-up of a randomized controlled trial.
Isanaka S; Langendorf C; McNeal MM; Meyer N; Plikaytis B; Garba S; Sayinzoga-Makombe N; Soumana I; Guindo O; Makarimi R; Scherrer MF; Adehossi E; Ciglenecki I; Grais RF
PLoS Med; 2021 Jul; 18(7):e1003655. PubMed ID: 34214095
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of a Low-Cost, Heat-Stable Oral Rotavirus Vaccine in Niger.
Isanaka S; Guindo O; Langendorf C; Matar Seck A; Plikaytis BD; Sayinzoga-Makombe N; McNeal MM; Meyer N; Adehossi E; Djibo A; Jochum B; Grais RF
N Engl J Med; 2017 Mar; 376(12):1121-1130. PubMed ID: 28328346
[TBL] [Abstract][Full Text] [Related]
4. Safety of the pentavalent rotavirus vaccine (PRV), RotaTeq(®), in Kenya, including among HIV-infected and HIV-exposed infants.
Laserson KF; Nyakundi D; Feikin DR; Nyambane G; Cook E; Oyieko J; Ojwando J; Rivers SB; Ciarlet M; Neuzil KM; Breiman RF
Vaccine; 2012 Apr; 30 Suppl 1():A61-70. PubMed ID: 22520138
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial.
Armah GE; Sow SO; Breiman RF; Dallas MJ; Tapia MD; Feikin DR; Binka FN; Steele AD; Laserson KF; Ansah NA; Levine MM; Lewis K; Coia ML; Attah-Poku M; Ojwando J; Rivers SB; Victor JC; Nyambane G; Hodgson A; Schödel F; Ciarlet M; Neuzil KM
Lancet; 2010 Aug; 376(9741):606-14. PubMed ID: 20692030
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial.
Zaman K; Dang DA; Victor JC; Shin S; Yunus M; Dallas MJ; Podder G; Vu DT; Le TP; Luby SP; Le HT; Coia ML; Lewis K; Rivers SB; Sack DA; Schödel F; Steele AD; Neuzil KM; Ciarlet M
Lancet; 2010 Aug; 376(9741):615-23. PubMed ID: 20692031
[TBL] [Abstract][Full Text] [Related]
7. A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants.
Kulkarni PS; Desai S; Tewari T; Kawade A; Goyal N; Garg BS; Kumar D; Kanungo S; Kamat V; Kang G; Bavdekar A; Babji S; Juvekar S; Manna B; Dutta S; Angurana R; Dewan D; Dharmadhikari A; Zade JK; Dhere RM; Fix A; Power M; Uprety V; Parulekar V; Cho I; Chandola TR; Kedia VK; Raut A; Flores J;
Vaccine; 2017 Oct; 35(45):6228-6237. PubMed ID: 28967523
[TBL] [Abstract][Full Text] [Related]
8. Vaccines for preventing rotavirus diarrhoea: vaccines in use.
Bergman H; Henschke N; Hungerford D; Pitan F; Ndwandwe D; Cunliffe N; Soares-Weiser K
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD008521. PubMed ID: 34788488
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and lot-to-lot consistency of a ready to use liquid bovine-human reassortant pentavalent rotavirus vaccine (ROTASIIL - Liquid) in Indian infants.
Kawade A; Babji S; Kamath V; Raut A; Kumar CM; Kundu R; Venkatramanan P; Lalwani SK; Bavdekar A; Juvekar S; Dayma G; Patil R; Kulkarni M; Hegde A; Nayak D; Garg BS; Gupta S; Jategaonkar S; Bedi N; Maliye C; Ganguly N; Uttam KG; Niyogi P; Palkar S; Hanumante N; Goyal N; Arya A; Aslam M; Parulekar V; Dharmadhikari A; Gaikwad D; Zade J; Desai S; Kang G; Kulkarni PS
Vaccine; 2019 May; 37(19):2554-2560. PubMed ID: 30955982
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine.
Vesikari T; Matson DO; Dennehy P; Van Damme P; Santosham M; Rodriguez Z; Dallas MJ; Heyse JF; Goveia MG; Black SB; Shinefield HR; Christie CD; Ylitalo S; Itzler RF; Coia ML; Onorato MT; Adeyi BA; Marshall GS; Gothefors L; Campens D; Karvonen A; Watt JP; O'Brien KL; DiNubile MJ; Clark HF; Boslego JW; Offit PA; Heaton PM;
N Engl J Med; 2006 Jan; 354(1):23-33. PubMed ID: 16394299
[TBL] [Abstract][Full Text] [Related]
11. Efficacy, safety and immunogenicity of a human rotavirus vaccine (RIX4414) in Hong Kong children up to three years of age: a randomized, controlled trial.
Lau YL; Nelson EA; Poon KH; Chan PK; Chiu S; Sung R; Leung CW; Ng D; Ma YM; Chan D; Lee TL; Tang J; Kwan YW; Ip P; Ho M; Fung LW; Tang H; Suryakiran PV; Han HH; Bock H;
Vaccine; 2013 Apr; 31(18):2253-9. PubMed ID: 23499605
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian children in the second year of life.
Bhandari N; Rongsen-Chandola T; Bavdekar A; John J; Antony K; Taneja S; Goyal N; Kawade A; Kang G; Rathore SS; Juvekar S; Muliyil J; Arya A; Shaikh H; Abraham V; Vrati S; Proschan M; Kohberger R; Thiry G; Glass R; Greenberg HB; Curlin G; Mohan K; Harshavardhan GV; Prasad S; Rao TS; Boslego J; Bhan MK;
Vaccine; 2014 Aug; 32 Suppl 1():A110-6. PubMed ID: 25091663
[TBL] [Abstract][Full Text] [Related]
13. Safety, reactogenicity and immunogenicity of the human rotavirus vaccine in preterm European Infants: a randomized phase IIIb study.
Omenaca F; Sarlangue J; Szenborn L; Nogueira M; Suryakiran PV; Smolenov IV; Han HH;
Pediatr Infect Dis J; 2012 May; 31(5):487-93. PubMed ID: 22228231
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis.
Ruiz-Palacios GM; Pérez-Schael I; Velázquez FR; Abate H; Breuer T; Clemens SC; Cheuvart B; Espinoza F; Gillard P; Innis BL; Cervantes Y; Linhares AC; López P; Macías-Parra M; Ortega-Barría E; Richardson V; Rivera-Medina DM; Rivera L; Salinas B; Pavía-Ruz N; Salmerón J; Rüttimann R; Tinoco JC; Rubio P; Nuñez E; Guerrero ML; Yarzábal JP; Damaso S; Tornieporth N; Sáez-Llorens X; Vergara RF; Vesikari T; Bouckenooghe A; Clemens R; De Vos B; O'Ryan M;
N Engl J Med; 2006 Jan; 354(1):11-22. PubMed ID: 16394298
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study.
Linhares AC; Velázquez FR; Pérez-Schael I; Sáez-Llorens X; Abate H; Espinoza F; López P; Macías-Parra M; Ortega-Barría E; Rivera-Medina DM; Rivera L; Pavía-Ruz N; Nuñez E; Damaso S; Ruiz-Palacios GM; De Vos B; O'Ryan M; Gillard P; Bouckenooghe A;
Lancet; 2008 Apr; 371(9619):1181-9. PubMed ID: 18395579
[TBL] [Abstract][Full Text] [Related]
16. Effect of human rotavirus vaccine on severe diarrhea in African infants.
Madhi SA; Cunliffe NA; Steele D; Witte D; Kirsten M; Louw C; Ngwira B; Victor JC; Gillard PH; Cheuvart BB; Han HH; Neuzil KM
N Engl J Med; 2010 Jan; 362(4):289-98. PubMed ID: 20107214
[TBL] [Abstract][Full Text] [Related]
17. Safety and immunogenicity of the Rotavac and Rotasiil rotavirus vaccines administered in an interchangeable dosing schedule among healthy Indian infants: a multicentre, open-label, randomised, controlled, phase 4, non-inferiority trial.
Kanungo S; Chatterjee P; Bavdekar A; Murhekar M; Babji S; Garg R; Samanta S; Nandy RK; Kawade A; Boopathi K; Kanagasabai K; Kamal VK; Kumar VS; Gupta N; Dutta S
Lancet Infect Dis; 2022 Aug; 22(8):1191-1199. PubMed ID: 35588754
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of a pentavalent live human-bovine reassortant rotavirus vaccine (RV5) in healthy Chinese infants: A randomized, double-blind, placebo-controlled trial.
Mo Z; Mo Y; Li M; Tao J; Yang X; Kong J; Wei D; Fu B; Liao X; Chu J; Qiu Y; Hille DA; Nelson M; Kaplan SS
Vaccine; 2017 Oct; 35(43):5897-5904. PubMed ID: 28935470
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy premature infants.
Goveia MG; Rodriguez ZM; Dallas MJ; Itzler RF; Boslego JW; Heaton PM; DiNubile MJ;
Pediatr Infect Dis J; 2007 Dec; 26(12):1099-104. PubMed ID: 18043445
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of the oral pentavalent rotavirus vaccine in Mali.
Sow SO; Tapia M; Haidara FC; Ciarlet M; Diallo F; Kodio M; Doumbia M; Dembélé RD; Traoré O; Onwuchekwa UU; Lewis KD; Victor JC; Steele AD; Neuzil KM; Kotloff KL; Levine MM
Vaccine; 2012 Apr; 30 Suppl 1():A71-8. PubMed ID: 22520140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
